helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: People who receive a 4-drug regimen for Helicobacter pylori and aloe vera syrup. The 4-drug regimen includes: amoxicillin 500 mg, two tablets, twice a day, bismuth
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Suspicion of H. pylori infection and indication of endoscopy with the approval of gastroenterologist Willingness to participate in research No history of receiving H. pylori treatment Age 18 to 65 years
Exclusion criteria
Exclusion criteria: pregnancy breastfeeding History of liver diseases History of allergy to aloe vera
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: At the time of first visit, two weeks after treatment and four weeks after treatment. Method of measurement: Clinical symptom assessment checklist (heartburn, regurgitation, difficulty swallowing, bloating, nausea/vomiting, acid reflux).;Response to treatment. Timepoint: Before starting treatment and one month after treatment. Method of measurement: Helicobacter pylori stool antigen test.;Side effects of treatment. Timepoint: Two weeks after treatment and four weeks after treatment. Method of measurement: Side effect checklist (including headache, constipation, dizziness, diarrhea, abdominal pain, flatulence, nausea/vomiting). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Sedighi Badi
Kashan University of Medical Sciences
Outcome results
None listed